Viewing Study NCT06251934


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-02-04 @ 5:42 AM
Study NCT ID: NCT06251934
Status: COMPLETED
Last Update Posted: 2024-02-09
First Post: 2024-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With BRAF-Positive Metastatic Melanoma
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module